Hyperandrogenism induces a proinflammatory TNF-α response to glucose ingestion in a receptor-dependent fashion

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages

  González, Frank ^a   Sia, Chang Ling ^a   Bearson, Dawn M ^b   Blair, Hilary E ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTENEDIONE; FLUTAMIDE; GLUCOSE; INSULIN; MESSENGER RNA; PLACEBO; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; HYPERANDROGENISM; IN VITRO STUDY; IN VIVO STUDY; INSULIN SENSITIVITY; MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ANDROSTENEDIONE; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE; HUMANS; HYPERANDROGENISM; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; RECEPTORS, ANDROGEN; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899906253     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4109     Document Type: Article

References (34)

1. Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95:2038-2049.
2. Kn ochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078-3082.
3. Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950womenreferred because o f clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91:2-6.
4. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165-1174.
5. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50:113-116.
6. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83: 2001-2005.
7. Chanock SJ, el Benna J, Smith RM, Babior BM. The respiratory burst oxidase. J Biol Chem. 1994;269:24519-24522.
8. Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996;347:444-445.
9. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor-inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA. 1994;91:4854-4858.
10. González F, Minium J, Rote NS, Kirwan JP. Hyperglycemia alters tumor necrosis factor-release from mononuclear cells i n women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90:5336-5342.
11. González F Rote NS Minium J Kirwan JP. Insulin sensitivity and hyperandrogenism in polycystic ovary syndrome are related to activated nuclear factor-B from mononuclear cells in the fasting state. In Proceedings from the 89th Annual Meeting of The Endocrine Society June 2-5, 2007 Toronto, ON, Canada. Abstract OR50-3.
12. González F, Sia CL, ShepardMK,Rote NS, Minium J. Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weightwomenwith polycystic ovary syndrome. J Clin Endocrinol Metab. 2012;97:4071-4079.
13. González F, Rote NS, Minium J, Kirwan JP. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-release in obese women with polycystic ovary syndrome. J Endocrinol. 2006;188: 521-529.
14. González F, Nair KS, Daniels JK, Basal E, Schimke JM. Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women. Am J Physiol Endocrinol Metab. 2012;302:E297-E306.
15. González F, Nair KS, Daniels JK, Basal E, Schimke JM, Blair HE. Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidati ve stress in lean reproductive-age women. J Clin Endocrinol Metab. 2012;97:2836-2843.
16. Ashcroft GS, Mills SJ. Androgen receptor-mediated inhibition of cutaneous wound healing. J Clin Invest. 2002;110:615-624.
17. Ripple MO, Henry WF, Schwarze SR, Wilding G, Weindruch R. Effect of antioxidants on androgen-induc ed AP-1 and NF-B DNAbinding activity in prostate carcinoma cells. J Natl Cancer Inst. 1999;91:1227-1232.
18. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-1470.
19. González F, Rote NS, Minium J, O'Leary VB, Kirwan JP. Obese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia. Obesity. 2007;15:2436-2444.
20. González F, Rote NS, Minium J, Kirwan JP. Reactive oxygen specie s-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:336-340.
21. González F, Rote NS, Minium J, Kirw an JP. Increased activation of nuclear factor-B triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91: 1508-1512.
22. González F, Sia CL, Shepar d MK, Rote NS, Minium J. Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weightwomenwith polycystic ovary syndrome. Hum Reprod. 2012;27:3560-3568.
23. D andona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor-B and stimulates I-B in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect J Clin Endocrinol Metab. 2001;86:3257-3265.
24. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation. 2004;110:1564-1571.
25. Labrie F, Simard J, Luu-The V, Pelletier G, Belghmi K, Bélanger A. Structure, regulation and role of 3-hydroxysteroid dehydrogenase, 17-hydroxysteroid dehydrogenase and aromatase enzymes in the formati on of sex steroids in classical and peripheral intracrine tissues. Baillieres Clin Endocrinol Metab. 1994;8:451-474.
26. Longcope C. Dehydroepiandrosterone metabolism. J Endocrinol. 1996;150(suppl):S125-S127.
27. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-in human obesity and insulin resistance. J Clin Invest . 1995;95:2409-2415.
28. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;11 2:1821-1830.
29. Fain JN, Bahouth SW, Madan AK. TNF-release by nonfat cells of adipose tissue. Intl J Obes. 2004;28:616-622.
30. Carmina E, Bucchieri S, Esposit o A, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007;92:2500-2505.
31. Hansen RD, Raja C, Aslani A, Smith RC, Allen BJ. Determination of skeletal muscle and fat-free mass by nuclear and dual-energy x-ray absorptiometry methods in men and women aged 51-84 y (1-3). Am J Clin Nutr. 1999;70:228-233.
32. Kimura M Tanaka S Yamada Y Kiuchi Y Yamakawa T Sekihara H. Dehydroepiandrosterone decreases serum tumor necrosis factor-and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats Endocrinology. 1998 139 3249-3253.
33. Zhang Z, Araghi-Niknam M, Liang B, et al. Prevention of immune dysfunction and vitamin E loss by dehydroepiandrosterone and melatonin supplementation during murine retrovirus infection. Immunology. 1999;96:291-297.
34. Barkhausen T, Hildebrand F, Krettek C, van Griensven M. DHEAdependent and organ-specific regulation of TNF-mRNA expression in a murine polymicrobial sepsis and trauma model. Crit Care. 2009;13:R114.